{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:58:30Z","timestamp":1791496710060,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jconrel.2020.10.052","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T22:27:31Z","timestamp":1603924051000},"page":"1249-1261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity"],"prefix":"10.1016","volume":"329","author":[{"given":"Pengfei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.10.052_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0010","first-page":"175","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","author":"Pao","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0015","first-page":"895","article-title":"Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer","volume":"31","author":"Welsh","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0020","first-page":"629","article-title":"Osimertinib or platinum-Pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0025","first-page":"41","article-title":"Overall survival with Osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0030","first-page":"560","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0035","first-page":"129","article-title":"Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0040","first-page":"229","article-title":"Macrophages and cancer: from mechanisms to therapeutic implications","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0045","first-page":"1447","article-title":"Tumor-associated macrophages: a short compendium","volume":"76","author":"Prenen","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0050","first-page":"828","article-title":"Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies","volume":"8","author":"Genard","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0055","first-page":"2674","article-title":"Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy","volume":"9","author":"Zhao","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0060","first-page":"12","article-title":"Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin\/fenretinide","volume":"287","author":"Mo","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0065","first-page":"7684","article-title":"Reprogramming tumor-associated macrophages to reverse EGFR(T790M) resistance by dual-targeting codelivery of Gefitinib\/Vorinostat","volume":"17","author":"Peng","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0070","article-title":"Remodeling tumor-associated macrophages and neovascularization overcomes EGFR(T790M) -associated drug resistance by PD-L1 Nanobody-mediated Codelivery","volume":"14","author":"Yin","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0075","first-page":"6122","article-title":"BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0080","first-page":"6387","article-title":"FROUNT is a common regulator of CCR2 and CCR5 signaling to control directional migration","volume":"183","author":"Toda","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0085","first-page":"609","article-title":"Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties","volume":"11","author":"Terashima","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0090","first-page":"11238","article-title":"Macrophages regulate the angiogenic switch in a mouse model of breast cancer","volume":"66","author":"Lin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0095","first-page":"814","article-title":"Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis","volume":"456","author":"Stockmann","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0100","article-title":"Dual-targeting to cancer cells and M2 macrophages via biomimetic delivery of mannosylated albumin nanoparticles for drug-resistant cancer therapy","volume":"27","author":"Zhao","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0105","first-page":"3860","article-title":"Disulfiram when combined with copper enhances the therapeutic effects of Temozolomide for the treatment of glioblastoma","volume":"22","author":"Lun","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0110","first-page":"194","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0115","first-page":"2004","article-title":"Receptor mediated uptake of peptides that bind the human transferrin receptor","volume":"268","author":"Lee","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0120","first-page":"27","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0125","first-page":"9999","article-title":"Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for Antiglioma therapy","volume":"10","author":"Lin","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0130","first-page":"1442","article-title":"Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells","volume":"137","author":"Duke","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0135","first-page":"1322","article-title":"Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model","volume":"12","author":"Abou-Elkacem","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0140","first-page":"1","article-title":"Tumor promoting role of anti-tumor macrophages in tumor microenvironment","volume":"316","author":"Goswami","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0145","first-page":"6425","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0150","first-page":"206","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0155","first-page":"4926","article-title":"TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice","volume":"155","author":"Maeda","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0160","first-page":"17009","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0165","first-page":"1180","article-title":"Regorafenib in patients with antiangiogenic-naive and chemotherapy-refractory advanced colorectal cancer: results from a phase IIb trial","volume":"24","author":"Riechelmann","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0170","first-page":"1052","article-title":"Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination","volume":"19","author":"Yamaguchi","year":"2016","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0175","first-page":"G22","article-title":"Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM\/DSS mouse model of colon cancer","volume":"314","author":"Bader","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0180","first-page":"208","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0185","first-page":"97","article-title":"Regulation of tumor metastasis by myeloid-derived suppressor cells","volume":"66","author":"Condamine","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0190","first-page":"3","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0195","first-page":"357","article-title":"Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"28","author":"Jackman","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0200","first-page":"205","article-title":"Tumor microenvironment and cancer therapy resistance","volume":"380","author":"Sun","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2020.10.052_bb0205","first-page":"3933","article-title":"The role of tumor microenvironment in therapeutic resistance","volume":"8","author":"Son","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0210","first-page":"462","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2020.10.052_bb0215","first-page":"230","article-title":"Determination of inorganic phosphate with molybdate and triton X-100 without reduction","volume":"145","author":"Kyaw","year":"1985","journal-title":"Anal. Biochem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:15:43Z","timestamp":1759162543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920306337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"alternative-id":["S0168365920306337"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.052","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}